LiveVox Announces Third Quarter 2021 Financial Results
LiveVox reported a 20.2% year-over-year increase in total revenue for Q3 2021, reaching $30.5 million. Contract revenue also surged by 26.3% to $23.1 million. Despite these gains, the company experienced a net loss of $11.3 million, compared to a minor loss of $0.3 million in Q3 2020. Looking ahead, LiveVox expects Q4 total revenue to be between $31.2 million and $32.2 million, indicating 11% to 15% growth year-over-year, but anticipates a decline in excess usage revenue.
- Total revenue increased by 20.2% to $30.5 million in Q3 2021.
- Contract revenue rose by 26.3% to $23.1 million.
- Achieved record bookings in the quarter, indicating strong demand.
- Largest new logo deal ever with ARR of $3.3 million.
- Guidance for Q4 indicates 11% to 15% revenue growth.
- Net loss of $11.3 million for Q3 2021, compared to a $0.3 million loss in Q3 2020.
- Adjusted EBITDA loss of $6.3 million, down from a positive adjusted EBITDA of $2.7 million.
- Excess usage revenue expected to decline by 4% to 9% year-over-year in Q4.
Third quarter total revenue of
Third quarter contract revenue of
“We executed incredibly well in Q3, highlighted by record revenue of
Third Quarter 2021 Financial Highlights
-
Revenue2: Total revenue for the third quarter of 2021 was
, up$30.5 million 20.2% compared to in the third quarter of 2020.$25.4 million -
Contract Revenue: Contract revenue was
, up$23.1 million 26.3% compared to for the third quarter of 2020.$18.2 million -
Gross Profit: Gross profit was
, up$17.0 million 8.4% compared to for the third quarter of 2020.$15.7 million -
Non-GAAP Gross Profit3 and Non-GAAP Gross Margin3: Non-GAAP gross profit was
, up$18.1 million 8.5% compared to for the third quarter of 2020; Non-GAAP gross margin was$16.7 million 59.5% after adjusting for stock-based compensation, depreciation and amortization and long-term incentive compensation triggered by the closing of the merger withCrescent Acquisition Corp. during the quarter, compared to65.9% in the third quarter of 2020. -
Net loss: Net loss was
for the third quarter of 2021, compared to net loss of$11.3 million for the third quarter of 2020.$0.3 million -
Adjusted EBITDA3: Adjusted EBITDA loss was
for the third quarter of 2021, compared to Adjusted EBITDA of$6.3 million for the third quarter of 2020.$2.7 million
_____________________________
1 ARR is defined as the annualized recurring revenue of an active subscription contract.
2 Total revenue is comprised of recurring subscription revenue and implementation revenue. Subscription revenue is comprised of contract revenue (revenue derived from usage committed under contract) and excess usage revenue (revenue derived from usage amounts higher than the minimum usage under contract).
3 Additional information regarding the non-GAAP financial measures discussed in this release, including an explanation of these measures and how each is calculated, is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of GAAP to non-GAAP financial measures has also been provided in the financial tables included below.
Business Outlook
In determining the financial guidance to provide to investors, the Company considered its recent business trends and financial results, current growth plans, strategic initiatives, global economic outlook and the continued uncertainty of COVID-19 and its potential impact on the Company’s results. Since the beginning of the COVID-19 pandemic, excess usage revenue has been negatively impacted by the effect of government stimulus provided to consumers in response to the COVID-19 pandemic, including, without limitation, direct stimulus payments to consumers, enhanced and extended unemployment benefits, rent abatements and mortgage and student loan forbearances. These programs have reduced consumer credit origination and servicing activity for a significant number of the Company’s customers. In determining the financial guidance for the fourth quarter and the full year 2021 set forth below, the Company has assumed that the negative impact to excess usage revenue from such stimulus will remain the same as current levels for the remainder of the year. As such,
-
Fourth Quarter 2021 Guidance:
-
Total revenue is expected to be in the range of
to$31.2 , representing growth of$32.2 million 11% to15% year-over-year. -
Contract revenue is expected to be in the range of
to$23.9 , representing growth of$24.4 million 19% to22% year-over-year. -
Excess usage revenue is expected to be in the range of
to$7.3 , representing a decrease of$7.8 million 4% to9% year-over-year, assuming that the usage multiplier (total revenue divided by contract revenue) remains at current pandemic-impacted levels for the fourth quarter.
-
Total revenue is expected to be in the range of
-
Full Year 2021 Guidance:
-
Total revenue is now expected to be in the range of
to$118.6 , representing growth of$119.6 million 16% to17% year-over-year. -
Contract revenue is now expected to be in the range of
to$90.1 , representing growth of$90.6 million 25% to26% year-over-year. -
Excess usage revenue is expected to be in the range of
to$28.5 , representing a decline of$29.0 million 6% to7% year-over-year, assuming that the usage multiplier (total revenue divided by contract revenue) remains at current pandemic-impacted levels for the remainder of the year.
-
Total revenue is now expected to be in the range of
-
Preliminary Full Year 2022 Guidance:
-
For the full year 2022, while we are still not providing formal guidance, we do reaffirm a minimum year-over-year growth rate in Contract Revenue of
25% based on our recent bookings momentum.
-
For the full year 2022, while we are still not providing formal guidance, we do reaffirm a minimum year-over-year growth rate in Contract Revenue of
Quarterly Conference Call
About
Forward-Looking Statements
Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements relating to expected bookings, expected revenue and annual recurring revenue from contracts, growth expectations, and future financial results, including guidance. These statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside LiveVox’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Any such forward-looking statements are made pursuant to the safe harbor provisions available under applicable securities laws and speak only as of the date of this presentation.
Important factors, among others, that may affect actual results or outcomes include the inability to recognize the anticipated benefits of the business combination with
The information contained in this press release is summary information that is intended to be considered in the context of LiveVox’s
Consolidated Statements of Operations and Comprehensive Loss
|
|||||||||||||||||||
|
For the three months ended
|
|
For the nine months ended
|
||||||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
Revenue |
$ |
30,507 |
|
|
|
$ |
25,390 |
|
|
|
$ |
87,365 |
|
|
|
$ |
74,414 |
|
|
Cost of revenue |
13,479 |
|
|
|
9,682 |
|
|
|
46,274 |
|
|
|
29,267 |
|
|
||||
Gross profit |
17,028 |
|
|
|
15,708 |
|
|
|
41,091 |
|
|
|
45,147 |
|
|
||||
Operating expenses |
|
|
|
|
|
|
|
||||||||||||
Sales and marketing expense |
12,227 |
|
|
|
6,552 |
|
|
|
48,820 |
|
|
|
21,653 |
|
|
||||
General and administrative expense |
7,642 |
|
|
|
3,246 |
|
|
|
37,159 |
|
|
|
9,705 |
|
|
||||
Research and development expense |
8,130 |
|
|
|
5,157 |
|
|
|
44,479 |
|
|
|
14,660 |
|
|
||||
Total operating expenses |
27,999 |
|
|
|
14,955 |
|
|
|
130,458 |
|
|
|
46,018 |
|
|
||||
Income (loss) from operations |
(10,971 |
) |
|
|
753 |
|
|
|
(89,367 |
) |
|
|
(871 |
) |
|
||||
Interest expense, net |
1,033 |
|
|
|
973 |
|
|
|
2,918 |
|
|
|
2,926 |
|
|
||||
Change in the fair value of warrant liability |
(300 |
) |
|
|
— |
|
|
|
(675 |
) |
|
|
— |
|
|
||||
Other expense (income), net |
(460 |
) |
|
|
(6 |
) |
|
|
(435 |
) |
|
|
76 |
|
|
||||
Total other expense, net |
273 |
|
|
|
967 |
|
|
|
1,808 |
|
|
|
3,002 |
|
|
||||
Pre-tax loss |
(11,244 |
) |
|
|
(214 |
) |
|
|
(91,175 |
) |
|
|
(3,873 |
) |
|
||||
Provision for income taxes |
100 |
|
|
|
116 |
|
|
|
187 |
|
|
|
529 |
|
|
||||
Net loss |
$ |
(11,344 |
) |
|
|
$ |
(330 |
) |
|
|
$ |
(91,362 |
) |
|
|
$ |
(4,402 |
) |
|
Comprehensive loss |
|
|
|
|
|
|
|
||||||||||||
Net loss |
(11,344 |
) |
|
|
(330 |
) |
|
|
(91,362 |
) |
|
|
(4,402 |
) |
|
||||
Other comprehensive income (loss) |
(41 |
) |
|
|
15 |
|
|
|
(27 |
) |
|
|
(99 |
) |
|
||||
Comprehensive loss |
$ |
(11,385 |
) |
|
|
$ |
(315 |
) |
|
|
$ |
(91,389 |
) |
|
|
$ |
(4,501 |
) |
|
Net loss per share—basic and diluted |
$ |
(0.12 |
) |
|
|
$ |
— |
|
|
|
$ |
(1.20 |
) |
|
|
$ |
(0.07 |
) |
|
Weighted average shares outstanding—basic and diluted |
91,444 |
|
|
|
66,637 |
|
|
|
76,122 |
|
|
|
66,637 |
|
|
||||
Consolidated Balance Sheets
|
|||||||||
|
As of |
||||||||
|
September
|
|
December
|
||||||
|
(Unaudited) |
|
|
||||||
ASSETS |
|
|
|
||||||
Current assets: |
|
|
|
||||||
Cash and cash equivalents |
$ |
104,980 |
|
|
|
$ |
18,098 |
|
|
Restricted cash, current |
— |
|
|
|
1,368 |
|
|
||
Accounts receivable, net |
17,052 |
|
|
|
13,817 |
|
|
||
Deferred sales commissions, current |
2,490 |
|
|
|
1,521 |
|
|
||
Prepaid expenses and other current assets |
6,948 |
|
|
|
2,880 |
|
|
||
Total Current Assets |
131,470 |
|
|
|
37,684 |
|
|
||
Property and equipment, net |
3,286 |
|
|
|
3,505 |
|
|
||
|
47,481 |
|
|
|
47,481 |
|
|
||
Intangible assets, net |
21,310 |
|
|
|
18,688 |
|
|
||
Operating lease right-of-use assets |
5,897 |
|
|
|
3,858 |
|
|
||
Deposits and other |
687 |
|
|
|
2,334 |
|
|
||
Deferred sales commissions, net of current |
6,219 |
|
|
|
3,208 |
|
|
||
Deferred tax asset |
79 |
|
|
|
— |
|
|
||
Restricted cash, net of current |
100 |
|
|
|
100 |
|
|
||
Total Assets |
$ |
216,529 |
|
|
|
$ |
116,858 |
|
|
|
|
|
|
||||||
LIABILITIES & STOCKHOLDERS’ EQUITY |
|
|
|
||||||
Current liabilities: |
|
|
|
||||||
Accounts payable |
$ |
4,275 |
|
|
|
$ |
3,521 |
|
|
Accrued expenses |
12,949 |
|
|
|
11,667 |
|
|
||
Deferred revenue, current |
1,074 |
|
|
|
1,140 |
|
|
||
Term loan, current |
561 |
|
|
|
1,440 |
|
|
||
Operating lease liabilities, current |
1,894 |
|
|
|
1,353 |
|
|
||
Finance lease liabilities, current |
80 |
|
|
|
392 |
|
|
||
Total current liabilities |
20,833 |
|
|
|
19,513 |
|
|
||
Long term liabilities: |
|
|
|
||||||
Line of credit |
— |
|
|
|
4,672 |
|
|
||
Deferred revenue, net of current |
249 |
|
|
|
237 |
|
|
||
Term loan, net of current |
54,572 |
|
|
|
54,604 |
|
|
||
Operating lease liabilities, net of current |
4,547 |
|
|
|
3,088 |
|
|
||
Finance lease liabilities, net of current |
18 |
|
|
|
38 |
|
|
||
Deferred tax liability, net |
— |
|
|
|
193 |
|
|
||
Warrant liability |
1,333 |
|
|
|
— |
|
|
||
Other long-term liabilities |
370 |
|
|
|
372 |
|
|
||
Total liabilities |
81,922 |
|
|
|
82,717 |
|
|
||
|
|
|
|
||||||
Commitments and contingencies (Note 10 and 22) |
|
|
|
||||||
Stockholders’ equity: |
|
|
|
||||||
Preferred stock, |
— |
|
|
|
— |
|
|
||
Common stock, |
9 |
|
|
|
7 |
|
|
||
Additional paid-in capital |
251,021 |
|
|
|
59,168 |
|
|
||
Accumulated other comprehensive loss |
(233 |
) |
|
|
(206 |
) |
|
||
Accumulated deficit |
(116,190 |
) |
|
|
(24,828 |
) |
|
||
Total stockholders’ equity |
134,607 |
|
|
|
34,141 |
|
|
||
Total liabilities & stockholders’ equity |
$ |
216,529 |
|
|
|
$ |
116,858 |
|
|
Consolidated Statements of Cash Flows
|
|||||||||
|
For the nine months ended
|
||||||||
|
2021 |
|
2020 |
||||||
Operating activities: |
|
|
|
||||||
Net loss |
$ |
(91,362 |
) |
|
|
$ |
(4,402 |
) |
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
|
|
|
||||||
Depreciation and amortization |
1,475 |
|
|
|
1,377 |
|
|
||
Amortization of identified intangible assets |
3,358 |
|
|
|
3,142 |
|
|
||
Amortization of deferred loan origination costs |
102 |
|
|
|
107 |
|
|
||
Amortization of deferred sales commissions |
1,368 |
|
|
|
887 |
|
|
||
Non-cash lease expense |
1,207 |
|
|
|
898 |
|
|
||
Stock compensation expense |
1,458 |
|
|
|
470 |
|
|
||
Equity incentive bonus |
32,863 |
|
|
|
— |
|
|
||
Bad debt expense |
110 |
|
|
|
624 |
|
|
||
Loss on disposition of asset |
— |
|
|
|
10 |
|
|
||
Deferred income tax benefit |
(272 |
) |
|
|
(382 |
) |
|
||
Change in the fair value of the warrant liability |
(675 |
) |
|
|
— |
|
|
||
Offering cost associated with Warrants recorded as liabilities |
41 |
|
|
|
— |
|
|
||
Changes in assets and liabilities |
|
|
|
||||||
Accounts receivable |
(2,648 |
) |
|
|
1,892 |
|
|
||
Other assets |
(2,514 |
) |
|
|
(405 |
) |
|
||
Deferred sales commissions |
(5,347 |
) |
|
|
(1,985 |
) |
|
||
Accounts payable |
1,725 |
|
|
|
460 |
|
|
||
Accrued expenses |
1,225 |
|
|
|
1,696 |
|
|
||
Deferred revenue |
(54 |
) |
|
|
145 |
|
|
||
Operating lease liabilities |
(1,202 |
) |
|
|
(904 |
) |
|
||
Other long-term liabilities |
(2 |
) |
|
|
(5 |
) |
|
||
Net cash provided by (used in) operating activities |
(59,144 |
) |
|
|
3,625 |
|
|
||
Investing activities: |
|
|
|
||||||
Purchases of property and equipment |
(1,210 |
) |
|
|
(434 |
) |
|
||
Acquisition of businesses, net of cash acquired |
— |
|
|
|
(20 |
) |
|
||
Asset acquisition |
1,326 |
|
|
|
— |
|
|
||
Net cash provided by (used in) investing activities |
116 |
|
|
|
(454 |
) |
|
||
Financing activities: |
|
|
|
||||||
Proceeds from Merger and PIPE financing, net of cash paid |
157,383 |
|
|
|
— |
|
|
||
Repayment on loan payable |
(1,676 |
) |
|
|
(864 |
) |
|
||
Repayment of drawdown on line of credit |
(4,672 |
) |
|
|
4,672 |
|
|
||
Debt issuance costs |
(153 |
) |
|
|
— |
|
|
||
Payment of contingent consideration liability |
(5,969 |
) |
|
|
— |
|
|
||
Repayments on finance lease obligations |
(331 |
) |
|
|
(582 |
) |
|
||
Net cash provided by financing activities |
144,582 |
|
|
|
3,226 |
|
|
||
Effect of foreign currency translation |
(40 |
) |
|
|
(102 |
) |
|
||
Net increase in cash, cash equivalents and restricted cash |
85,514 |
|
|
|
6,295 |
|
|
||
Cash, cash equivalents, and restricted cash beginning of period |
19,566 |
|
|
|
16,513 |
|
|
||
Cash, cash equivalents, and restricted cash end of period |
$ |
105,080 |
|
|
|
$ |
22,808 |
|
|
|
|
|
|
|
For the nine months ended
|
||||||
|
2021 |
|
2020 |
||||
Supplemental disclosure of cash flow information: |
|
|
|
||||
Interest paid |
$ |
2,828 |
|
|
$ |
2,836 |
|
Income taxes paid |
237 |
|
|
181 |
|
||
Supplemental schedule of noncash investing activities: |
|
|
|
||||
Additional right-of-use assets |
$ |
3,246 |
|
|
$ |
997 |
|
|
|
|
|
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets (dollars in thousands):
|
As of |
||||||
|
2021 |
|
2020 |
||||
Cash and cash equivalents |
$ |
104,980 |
|
|
$ |
21,348 |
|
Restricted cash, current |
— |
|
|
1,360 |
|
||
Restricted cash, net of current |
100 |
|
|
100 |
|
||
Total cash, cash equivalents and restricted cash |
$ |
105,080 |
|
|
$ |
22,808 |
|
Non-GAAP Financial Measures
Management uses non-GAAP financial measures to evaluate operating performance. We believe non-GAAP financial measures provide useful information to investors and others to understand and evaluate our operating results in the same manner as our management and board of directors and allows for better comparison of financial results among our competitors.
Adjusted EBITDA
We monitor Adjusted EBITDA, a non-generally accepted accounting principle (“Non-GAAP”) financial measure, to analyze our financial results and believe that it is useful to investors, as a supplement to
Non-GAAP Gross Profit and Non-GAAP Gross Margin Percentage
Management uses Non-GAAP gross profit and Non-GAAP gross margin percentage to evaluate operating performance and to determine resource allocation among our various product offerings. We believe Non-GAAP gross profit and Non-GAAP gross margin percentage provide useful information to investors and others to understand and evaluate our operating results in the same manner as our management and board of directors and allows for better comparison of financial results among our competitors. Non-GAAP gross profit and Non-GAAP gross margin percentage may not be comparable to similarly titled measures of other companies because other companies may not calculate Non-GAAP gross profit and Non-GAAP gross margin percentage or similarly titled measures in the same manner as we do.
Please see tables below for a reconciliation of non-GAAP measures to the most directly comparable GAAP measures for the periods presented.
GAAP Net Income (Loss) to Adjusted EBITDA
|
|||||||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
Net loss |
$ |
(11,344 |
) |
|
|
$ |
(330 |
) |
|
|
$ |
(91,362 |
) |
|
|
$ |
(4,402 |
) |
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||||||
Depreciation and amortization |
1,628 |
|
|
|
1,502 |
|
|
|
4,834 |
|
|
|
4,519 |
|
|
||||
Long-term equity incentive bonus and stock-based compensation expense |
2,069 |
|
|
|
252 |
|
|
|
72,035 |
|
|
|
749 |
|
|
||||
Interest expense, net |
1,033 |
|
|
|
973 |
|
|
|
2,918 |
|
|
|
2,926 |
|
|
||||
Change in the fair value of warrant liability |
(300 |
) |
|
|
— |
|
|
|
(675 |
) |
|
|
— |
|
|
||||
Other expense (income), net |
(460 |
) |
|
|
(6 |
) |
|
|
(435 |
) |
|
|
76 |
|
|
||||
Acquisition and financing related fees and expenses |
480 |
|
|
|
— |
|
|
|
1,521 |
|
|
|
25 |
|
|
||||
Transaction-related costs |
531 |
|
|
|
— |
|
|
|
1,834 |
|
|
|
— |
|
|
||||
|
(11 |
) |
|
|
171 |
|
|
|
135 |
|
|
|
602 |
|
|
||||
Provision for income taxes |
100 |
|
|
|
116 |
|
|
|
187 |
|
|
|
529 |
|
|
||||
Adjusted EBITDA |
$ |
(6,274 |
) |
|
|
$ |
2,678 |
|
|
|
$ |
(9,008 |
) |
|
|
$ |
5,024 |
|
|
GAAP Gross Profit to Adjusted Gross Profit
|
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Gross profit |
$ |
17,028 |
|
|
$ |
15,708 |
|
|
$ |
41,091 |
|
|
$ |
45,147 |
|
Depreciation and amortization |
927 |
|
|
944 |
|
|
2,785 |
|
|
2,864 |
|
||||
Long-term equity incentive bonus and stock-based compensation expense |
190 |
|
|
68 |
|
|
9,877 |
|
|
100 |
|
||||
Non-GAAP gross profit |
$ |
18,145 |
|
|
$ |
16,720 |
|
|
$ |
53,753 |
|
|
$ |
48,111 |
|
Non-GAAP gross margin % |
59.5 |
% |
|
65.9 |
% |
|
61.5 |
% |
|
64.7 |
% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211111006070/en/
Investor Contacts:
awaadt@livevox.com
livevoxIR@icrinc.com
Press contacts:
nbandy@livevox.com
livevoxPR@icrinc.com
Source:
FAQ
What are LiveVox's Q3 2021 total revenue figures?
How much did LiveVox's contract revenue increase in Q3 2021?
What is LiveVox's guidance for Q4 2021 total revenue?
What was LiveVox's net loss in Q3 2021?